"RIV/00216208:11120/09:00001672" . "\u0160tich, Vladim\u00EDr" . "0022-3751" . . "Bajzov\u00E1, Magda" . "Berlan, M." . "Marques, M. A." . "Langin, D." . "de Glisezinski, I." . . "3"^^ . "Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue" . "RIV/00216208:11120/09:00001672!RIV10-GA0-11120___" . "302011" . "Larrouy, D." . . . "Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue"@en . . "Adrenergic-receptors; Insulin secretion; Physical exercise"@en . . . "12"^^ . "The relative contribution of noradrenaline (norepinephrine) and adrenaline (epinephrine) in the control of lipid mobilization in subcutaneous adipose tissue (SCAT) during exercise was evaluated in men treated with a somatostatin analogue, octreotide. Eight lean and eight obese young men matched for age and physical fitness performed 60 min exercise bouts at 50% of their maximal oxygen consumption on two occasions: (1) during i.v. infusion of octreotide, and (2) during placebo infusion. Lipolysis and local blood flow changes in SCAT were evaluated using in situ microdialysis. Infusion of octreotide suppressed plasma insulin and growth hormone levels at rest and during exercise. It blocked the exercise-induced increase in plasma adrenaline while that of noradrenaline was unchanged. Plasma natriuretic peptides (NPs) level was higher at rest and during exercise under octreotide infusion in lean men. Under placebo, no difference was found in the exercise-induced increase in glycerol between the probe perfu" . . . "13" . "000267540500040" . "Journal of Physiology-London" . . . "11120" . . . "Lafontan, M." . "The relative contribution of noradrenaline (norepinephrine) and adrenaline (epinephrine) in the control of lipid mobilization in subcutaneous adipose tissue (SCAT) during exercise was evaluated in men treated with a somatostatin analogue, octreotide. Eight lean and eight obese young men matched for age and physical fitness performed 60 min exercise bouts at 50% of their maximal oxygen consumption on two occasions: (1) during i.v. infusion of octreotide, and (2) during placebo infusion. Lipolysis and local blood flow changes in SCAT were evaluated using in situ microdialysis. Infusion of octreotide suppressed plasma insulin and growth hormone levels at rest and during exercise. It blocked the exercise-induced increase in plasma adrenaline while that of noradrenaline was unchanged. Plasma natriuretic peptides (NPs) level was higher at rest and during exercise under octreotide infusion in lean men. Under placebo, no difference was found in the exercise-induced increase in glycerol between the probe perfu"@en . . . "Koppo, K." . "P(GA303/07/0840), S, Z(MSM0021620814)" . . "Crampes, F." . "US - Spojen\u00E9 st\u00E1ty americk\u00E9" . "587" . . "Pol\u00E1k, Jan" . "12"^^ . . "Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue" . . "[EA4B87B31F5A]" . . "Bulow, J." . "Adrenaline but not noradrenaline is a determinant of exercise-induced lipid mobilization in human subcutaneous adipose tissue"@en .